← Oncology Approval Tracker

FDA DECISION ·

Methotrexate Injection

methotrexate sodium · Hospira

FDA approvalNew or expanded indicationNon-Hodgkin lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

FDA broadened injectable methotrexate’s lymphoma labeling to include all non-Hodgkin lymphoma histologic subsets. The same supplement revised the oncology label and dosing instructions.

LAMPGEN ANALYSIS

Why it matters

This changes the labeled scope of an established injectable oncology drug and modernizes older indication language.

What research teams should watch

Use the revised label to verify histology, approved route and regimen-specific instructions.

PRIMARY RECORDS

Sources